We are excited to share the following opportunities to get involved with Canada’s health technology assessment agencies and the reimbursement review process. Your voice as a person impacted by myeloma is an invaluable contribution to decisions that impact our community.

Canada’s Drug Agency (CDA) is currently seeking knowledgeable and experienced individuals to join its expert and advisory committees.

Their annual call for nominations is now open for the following positions:

• 1 patient member on the Canadian Drug Expert Committee (CDEC)
• 2 members on the Patient and Community Advisory Committee (PCAC)

We are proud to already have a member of our community on the PCAC, but we encourage more individuals impacted by myeloma to apply and ensure our perspectives are represented across all committees.

Patient members should have experience as a patient or caregiver, a demonstrated interest in healthcare issues, and the ability to represent the patient interest at community, regional, or national levels.

How to Apply: Submit your nomination via the online form by Monday, March 31, 2025:
More Information

---

INESSS (Institut national d’excellence en santé et en services sociaux) is also compiling a register of caregivers, patients, and healthcare system users. Individuals selected from this register may be invited to collaborate on various healthcare projects, including those related to cancer, chronic pain, osteoporosis, and more. Participation may be remunerated.

How to Apply: Fill out the participation questionnaire
More information

Your involvement can make a meaningful impact on shaping decisions that affect access to treatments and healthcare services.